A tandem repeat of human telomerase reverse transcriptase (hTERT) and risk of breast cancer development and metastasis in Chinese women.

Telomerase reactivation, which prevents telomere shortening and maintains cell viability, is crucial for the continued growth or progression of cancer cells. A minisatellite tandem repeat, MNS16A, located in the downstream of the human telomerase reverse transcriptase (hTERT) gene was recently identified and reported to have an effect on hTERT expression and telomerase activity. The aim of this study was to test the hypothesis that the MNS16A variant is associated with risk of breast cancer development and metastasis. We genotyped MNS16A variant in hTERT in a case-control study of 1029 histologically confirmed breast cancer patients and 1107 cancer-free controls in Chinese women. The variant genotypes (302/271, 302/243 and 243/243) of MNS16A were associated with a significantly increased risk of breast cancer [adjusted odds ratio (OR) = 1.50, 95% confidence interval (CI) = 1.15-1.96], compared with the wild-type 302/302 genotype. In stratified analyses, we found that the 302/271 genotype was associated with a significantly increased risk of axillary lymph nodes metastasis (adjusted OR = 2.13, 95% CI = 1.05-4.33) compared with wild-type 302/302 genotype. These findings indicate that the MNS16A variant in the hTERT gene may contribute to the risk of breast cancer development and metastasis in Chinese women.

[1]  J. Potter,et al.  Timing of menarche and first full-term birth in relation to breast cancer risk. , 2007, American journal of epidemiology.

[2]  K. Hoang-Xuan,et al.  Association of telomerase gene hTERT polymorphism and malignant gliomas , 2007, Journal of Neuro-Oncology.

[3]  Hongbing Shen,et al.  Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: a case-control analysis , 2007, Breast Cancer Research and Treatment.

[4]  J. Murnane.  Telomeres and chromosome instability. , 2006, DNA repair.

[5]  K. Rudolph,et al.  Telomeres and telomerase in cancer stem cells. , 2006, European journal of cancer.

[6]  Luo Wang,et al.  Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Shay,et al.  TELOMERASE ACTIVITY IN GASTRIC CANCER Gastric Cancer , 2006 .

[8]  C. Glover,et al.  Gene expression profiling for hematopoietic cell culture , 2006 .

[9]  N. Krieger.  Exposure, susceptibility, and breast cancer risk: A hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/white differences, in breast cancer incidence , 1989, Breast Cancer Research and Treatment.

[10]  K. Chin,et al.  In situ analyses of genome instability in breast cancer , 2004, Nature Genetics.

[11]  Wonshik Han,et al.  Associations between Breast Cancer Susceptibility Gene Polymorphisms and Clinicopathological Features , 2004, Clinical Cancer Research.

[12]  B. Shpitz,et al.  Telomerase activity in ductal carcinoma in situ of the breast , 1999, Breast Cancer Research and Treatment.

[13]  Li Mao,et al.  Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer , 2003, Oncogene.

[14]  K. Loeb,et al.  Multiple mutations and cancer , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Li Mao,et al.  hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  T. Key,et al.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. , 2002, Journal of the National Cancer Institute.

[17]  F. Clavel-Chapelon,et al.  Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women , 2002, British Journal of Cancer.

[18]  R. Pallini,et al.  In situ detection of telomerase catalytic subunit mRNA in glioblastoma multiforme , 2000, International journal of cancer.

[19]  H. Hollema,et al.  Telomerase in (pre)neoplastic cervical disease. , 2000, Human pathology.

[20]  T. Sellers,et al.  Association of menstrual and reproductive factors with breast cancer risk: Results from the Shanghai breast cancer study , 2000, International journal of cancer.

[21]  J. Shay,et al.  High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  K. Loeb,et al.  Significance of multiple mutations in cancer. , 2000, Carcinogenesis.

[23]  S. Culine,et al.  Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations. , 2000, Cancer research.

[24]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[25]  G. Hagen,et al.  Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). , 1999, Gene.

[26]  Robert A. Weinberg,et al.  Expression of TERT in early premalignant lesions and a subset of cells in normal tissues , 1998, Nature Genetics.

[27]  D. Wallwiener,et al.  Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer , 1998, International journal of cancer.

[28]  C. Osborne,et al.  Telomerase activity and survival of patients with node-positive breast cancer. , 1997, Journal of the National Cancer Institute.

[29]  C B Harley,et al.  Telomerase catalytic subunit homologs from fission yeast and human. , 1997, Science.

[30]  June Corwin,et al.  Telomerase Catalytic Subunit Homologs from Fission Yeast and Human , 1997 .

[31]  J. Kelsey,et al.  Epidemiology of breast cancer. , 1990, Epidemiologic reviews.

[32]  K. Ebeling,et al.  [Epidemiology of breast cancer]. , 1988, Archiv fur Geschwulstforschung.